PECULIARITIES OF THE EFFECT OF AMINOADAMANTANE DERIVATIVES ON ETHANOL-INDUCED ATAXIA. SEDATION. AND HYPERLOCOMOTION IN MICE.
The influence of two aminoadamantane derivatives representing low-affinity NMDA receptor antagonists, which show antiparkinsonian-like activity both in animal models and in patients with Parkinson's disease, have been studied in vivo on mice with acute ethanol-induced disorders. N-(adamant-2-yl) hexamethyleneimine hydrochloride (himantane) in doses of 5--20 mg/kg, i.p., dose-dependently prevented ethanol-induced ataxia in CD-I mice, sedation in C57BI/6 mice, and hyperlocomotion in DBA/2 mice. At the same time, I -aminoadamantane (amantadine) in doses of 10 - 20 mg/kg, i.p., did not attenuate acute ethanol-induced (2 g/kg, i.p.) effects. Neither himantane nor amantadine influenced the duration of ethanol narcosis (5.5 g/kg, i.p.) in CD-I mice. The obtained data showed a difference of the pharmacodynamic profile of himantane as low-affinity NMDA receptor antagonist in interaction with ethanol at doses inducing behavioral disorders.